Lysosomal protease inhibitors induce meganeurites and tangle-like structures in entorhinohippocampal regions vulnerable to Alzheimer's disease

Experimental Neurology

Volumn 158, Issue 2, 1999, Pages 312-327

  Bi, Xiaoning ^a   Zhou, Jun ^a   Lynch, Gary ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aging; Alzheimer's disease; Cathepsin D; Entorhinal cortex; Hippocampus; Lysosome; Neurofibrillary tangles; Phosphorylation; Tau protein

Indexed keywords

PROTEINASE INHIBITOR; TAU PROTEIN;

AGING; ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; ENTORHINAL CORTEX; HIPPOCAMPUS; IMMUNOBLOTTING; LYSOSOME; NEUROFIBRILLARY TANGLE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0032837802     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1999.7087     Document Type: Article

References (56)

1. Baba M., Osumi M., Scott S. V., Klionsky D. J., Ohsumi Y. Two distinct pathways for targeting proteins from the cytoplasm to the vacuole/lysosome. J. Cell Biol. 139:1997;1687-1695.
2. Bahr B., Abai B., Gall C. M., Vanderklish P. W., Hoffman K. B., Lynch G. Induction of β-amyloid containing polypeptides in hippocampus: Evidence for a concomitant loss of synaptic proteins and interactions with an excitotoxin. Exp. Neurol. 129:1994;1-14.
3. Bahr B., Hoffman K., Yang A., Hess U., Glabe C., Lynch G. Amyloid beta-protein is selectively internalized by hippocampal field CA1 and causes neurons to accumulate amyloidogenic carboxyterminal fragments of the amyloid precursor protein. J. Comp. Neurol. 397:1998;139-147.
4. Bancroft J. D., Stevens A., Turner D. R. Theory and Practice of Histological Techniques. 1996;Churchill Livingstone, New York.
5. Bannay-Schwartz M., DeGuzman T., Kenessey A., Palkovits M., Lajtha A. The distribution of cathepsin D activity in adult and aging human brain regions. J. Neurochem. 58:1992;2207-2211.
6. Bednarski E., Lynch G. Cytosolic proteolysis of tau by cathepsin D in hippocampus following suppression of cathepsins B and L. J. Neurochem. 67:1996;1846-1855.
7. Bednarski E., Lynch G. Selective suppression of cathepsin L results from elevations in lysosomal pH and is followed by proteolysis of tau protein. NeuroReport. 9:1998;2089-2094.
8. Bednarski E., Ribak C. E., Lynch G. Suppression of cathepsins B and L causes a proliferation of lysosomes and the formation of meganeurites in hippocampus. J. Neurosci. 17:1997;4006-4021.
9. Bi X., Chen J., Baudry M. Calpain-mediated proteolysis of GluR1 subunits in organotypic hippocampal cultures following kainic acid treatment. Brain Res. 781:1998;355-357.
10. Braak E., Braak H., Mandelkow E.-M. A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol. 87:1994;554-567.
11. Braak H. Architectonics as seen by lipofuscin stains. Peters A., Jones E. G. Cerebral Cortex. 1984;59-104 Plenum, New York.
12. Braak H., Braak E. Ratio of pyramidal cells versus non-pyramidal cells in the human frontal isocortex and changes in ratio with aging and Alzheimer's disease. Prog. Brain Res. 70:1986;185-212.
13. Braak H., Braak E. Pathology of Alzheimer's disease. Calne D. B. Neurodegenerative Diseases. 1994;585-613 Saunders, Philadelphia.
14. 396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding. Neuron. 10:1993;1089-1099.
15. Caballero-Bleda M., Witter M. P. Regional and laminar organization of projections from the presubiculum and parasubiculum to the entorhinal cortex: An anterograde tracing study in the rat. J. Comp. Neurol. 328:1993;115-129.
16. Cataldo A., Thayer C., Bird E., Wheelock T., Nixon R. Lysosomal proteinase antigens are prominently localized within senile plaques of Alzheimer's disease: Evidence for a neuronal origin. Brain Res. 513:1990;181-192.
17. Cataldo A. M., Paskevich P. A., Kominami E., Nixon R. A. Lysosomal hydrolases of different classes are abnormally distributed in brain of patients with Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 88:1991;10998-11002.
18. Cataldo A. M., Barnett J. L., Berman S. A., Li J., Quarless S., Bursztajn S., Lippa C., Nixon R. A. Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: Evidence for early up-regulation of the endosomal-lysosomal system. Neuron. 14:1995;671-680.
19. Cataldo A. M., Hamilton D. J., Barnett J. L., Paskevich P. A., Nixon R. A. Properties of the endosomal-lysosomal system in the human central nervous system: Disturbances mark most neurons in populations at risk to degenerate in Alzheimer's disease. J. Neurosci. 16:1996;186-199.
20. Deadwyler S., West J., Cotman C., Lynch G. Physiological studies of the reciprocal connections between the hippocampus and entorhinal cortex. Exp. Neurol. 49:1975;35-57.
21. Goedert M., Jakes J., Crowther R. A., Six J., Lubke U., Vandermeeren M., Cras P., Trojanowski J. Q., Lee V. M. Y. The abnormal phosphorylation of tau protein at Ser-202 in Alzheimer disease recapitulates phosphorylation during development. Proc. Natl. Acad. Sci. USA. 90:1993;5066-5070.
22. Greenberg S. G., Davies P. A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. Proc. Natl. Acad. Sci. USA. 87:1990;5827-5831.
23. Hirano A., Zimmerman H. M. Alzheimer's neurofibrillary changes. Arch. Neurol. 7:1962;227-242.
24. Ii K., Ito H., Koninami E., Hirano A. Abnormal distribution of cathepsin proteinases and endogenous inhibitor (cystatins) in the hippocampus of patients with Alzheimer's disease, Parkinsonism-dementia complex on Guam, and senile dementia and in the aged. Virchows Archiv. 423:1993;185-194.
25. Ivy G., Kanai S., Ohta M., Smith G., Sato Y., Kobayashi M., Kitani K. Lipofuscin-like substances accumulate rapidly in the brain, retina and internal organs with cysteine protease inhibition. Adv. Exp. Med. Biol. 266:1989;31-45.
26. Ivy G., Shottler F., Wenzel J., Baudry M., Lynch G. Inhibitors of lysosomal enzymes: Accumulation of lipofuscin-like dense bodies in the brain. Science. 226:1984;985-987.
27. Kenessey A., Banay-Schwartz M., DeGuzman T., Lajtha A. Increase in cathepsin D activity in rat brain in aging. J. Neurosci. Res. 23:1989;454-456.
28. Kenessey A., Nacharaju P., Yen S. Degradation of tau by lysosomal enzyme cathepsin D: Implication for Alzheimer neurofibrillary degeneration. J. Neurochem. 69:1997;2026-2038.
29. Laemmli U. K. Cleavage of structural proteins during the assembly of the bacteriophage T4. Nature. 227:1970;680-685.
30. Landfield P., Braun L., Pitler T., Lindsey J., Lynch G. Hippocampal aging in rats: Amorphometric study of multiple variables in semithin sections. Neurobiol. Aging. 2:1981;265-275.
31. Lee W., Sodek J., McCulloch C. A. Role of integrins in regulation of collagen phagocytosis by human fibroblasts. J. Cell. Physiol. 168:1996;695-704.
32. Love S., Bridges L. R., Case C. P. Neurofibrillary tangles in Niemann-Pick disease type C. Brain. 118:1995;119-129.
33. Mann D. M. A. Sense and Senility: The Neuropathology of the Aged Human Brain. 1997;Chapman & Hall, New York.
34. March P. A., Thrall M. A., Brown D. E., Mitchell T. W., Lowenthal A. C., Walkley S. U. GABAergic neuroaxonal dystrophy and other cytopathological alterations in feline Niemann-Pick disease type C. Acta Neuropathol. 94:1997;164-172.
35. Nakamura Y., Takeda M., Suzuki H., Morita H., Tada K., Hariguchi S., Nishimura R. Lysosome instability in aged rat brain. Neurosci. Lett. 97:1989;215-220.
36. Nakanishi H., Tominaga K., Amano T., Hirotsu I., Inoue T., Yamamoto K. Age-related changes in activities and localizations of cathepsin D, E, B, and L in the rat brain tissues. Exp. Neurol. 126:1994;119-128.
37. Nieto A., Correas I., Montejo de Garcini E., Avila J. A modified form of microtubule-associated tau protein is the main component of paired helical filaments. Biochem. Biophys. Res. Commun. 154:1988;660-667.
38. Nieto A., Montejo de Garcini E., Correas I., Avila J. Characterization of tau protein present in microtubules and paired helical filaments of Alzheimer's disease patient's brain. J. Neurosci. 37:1990;163-170.
39. Nixon R., Cataldo A., Paskevich P., Hamilton D., Wheelock T., Kanaley-Andrews L. The lysosomal system in neurons. Involvement at multiple stages of Alzheimer's disease pathogenesis. Ann. N. Y. Acad. Sci. 647:1992;65-89.
40. Novak M. Truncated tau protein as a new marker for Alzheimer's disease. Acta Virol. (Praha). 38:1994;173-189.
41. Polet H. Effects of fibroblastic growth factor on protein degradation, the migration of nonhistone proteins to the nucleus and DNA synthesis in diploid fibroblasts. Exp. Cell Res. 169:1987;178-190.
42. Polet H. Effects of platelet-derived growth factors on degradation, nuclear translocation of nonhistone proteins, and DNA synthesis. Proc. Soc. Exp. Bio. Med. 199:1992;417-423.
43. Press B., Feng Y., Hoflack B., Wandinger-Ness A. Mutant Rab7 causes the accumulation of cathepsin D and cation-independent mannose 6-phosphate receptor in an early endocytic compartment. J. Cell Biol. 140:1998;1075-1089.
44. Probst A., Tolnay M., Langui D., Goedert M., Spillantini M. G. Pick's disease: Hyperphosphorylated tau protein segregates to the somatoaxonal compartment. Acta Neuropathol. 92:1996;588-596.
45. Purpura D. P., Suzuki K. Distortion of neuronal geometry and formation of aberrant synapses in neuronal storage disease. Brain Res. 116:1976;1-21.
46. Schwargel A., Mohan P., Cataldo A., Vonsattel J., Kowall N., Nixon R. Elevated levels of the endosomal-lysosomal proteinase cathepsin D in cerebrospinal fluid in Alzheimer disease. J. Neurochem. 64:1995;443-446.
47. Schworer C. M., Mortimore G. E. Glucagon-induced autophagy and proteolysis in rat liver: Mediation by selective deprivation of intracellular amino acids. Proc. Natl. Acad. Sci. USA. 76:1979;3169-3173.
48. Shaw E., Dean R. T. The inhibition of macrophage protein turnover by a selective inhibitor of thiol proteinases. Biochem. J. 186:1980;385-390.
49. Stoppini L., Buchs P., Muller D. A simple method for organotypic cultures of nervous tissue. J. Neurosci. Methods. 37:1991;173-182.
50. Straub M., Bredschneider M., Thumm M. AUT3, a serine/threonine kinase gene, is essential for autophagocytosis in Saccharomyces cerevisiae. J. Bacteriol. 179:1997;3875-3883.
51. Su J. H., Cummings B. J., Cotman C. W. Plaque biogenesis in brain aging and Alzheimer's disease. I. Progressive changes in phosphorylation states of paired helical filaments and neurofilaments. Brain Res. 739:1996;79-87.
52. Su J. H., Deng G., Cotman C. W. Transneuronal degeneration in the spread of Alzheimer's disease pathology: Immunohistochemical evidence for the transmission of tau hyperphosphorylation. Neurobiol. Dis. 4:1997;365-375.
53. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheet: Procedure and some applications. Proc. Natl. Acad. Sci. USA. 76:1979;4350-4354.
54. Wille H., Drewes G., Biernat J., Mandelkow E. M., Mandelkow E. Alzheimer-like paired helical filaments and antiparallel dimers formed from microtubule-associated protein tau in vitro. J. Cell Biol. 118:1992;573-584.
55. Witter M. P. Organization of the entorhinal-hippocampal system: A review of current anatomical data. Hippocampus. 3:1993;33-44.
56. Yong A. P., Bednarski E., Lynch G., Ribak C. E. Lysosomal dysfunction results in lamina specific meganeurite formation in frontal cortex. Exp. Neurol. 157:1999;150-160.